IGA MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE

Clinical trials for IGA MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE explained in plain language.

Never miss a new study

Get alerted when new IGA MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE trials appear

Sign up with your email to follow new studies for IGA MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Cancer-Fighting antibiotic trial targets precancerous blood cells

Disease control Recruiting now

This study is testing whether a short course of the antibiotic rifaximin can reduce abnormal blood protein levels in people with IgA MGUS, a condition that can sometimes turn into cancer. Fifty adults with IgA MGUS will be randomly assigned to either take the antibiotic pills for…

Matched conditions: IGA MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE

Phase: PHASE2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control

Last updated Mar 31, 2026 12:10 UTC

IGA MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE

Get alerted when new IGA MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE trials appear

Cancer-Fighting antibiotic trial targets precancerous blood cells